Royal Philips has introduced an “all-in-one breast ultrasound solution” for its EPIQ and Affiniti ultrasound systems with anatomical intelligence software and its eL 18-4 transducer. This solution, designed to help clinicians efficiently assess, monitor, and treat breast diseases, is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
The Philips' integrated breast solution combines four features that work seamlessly together for comprehensive and confident screening and diagnosis. These include:
Philips integrated breast ultrasound solution debuted. Appl Radiol.